Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, April 13, 2022
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
Kalpit Patel Downgraded (BCYC) to Hold and Decreased Target to $33 on, Apr 13th, 2022
Kalpit Patel of B. Riley Securities, Downgraded "Bicycle Therapeutics plc" (BCYC) to Hold and Decreased Target from $62 to $33 on, Apr 13th, 2022.
Kalpit has made no other calls on BCYC in the last 4 months.
There are 4 other peers that have a rating on BCYC. Out of the 4 peers that are also analyzing BCYC, 1 agrees with Kalpit's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Initiated at Hold and Held Target at $60 on, Monday, February 14th, 2022
These are the ratings of the 3 analyists that currently disagree with Kalpit
- Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $75 on, Tuesday, April 12th, 2022
- Reni Benjamin of "JMP Securities" Maintained at Buy with Decreased Target to $70 on, Thursday, March 3rd, 2022
- Jonathan Chang of "SVB Leerink" Initiated at Buy and Held Target at $70 on, Friday, December 17th, 2021
